RxNorm Semantic Concepts Index - 271
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "271".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 271 | Actin | Designated preferred name (PT) | NO | |
| RxCUI: 271 | Actin | Full form of descriptor (FN) | NO | |
| RxCUI: 2710 | Polymyxin E sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2710 | Polymyxin E sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 2710 | Polymyxin E sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 2710 | Polymyxin E sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 2710 | Polymyxin E sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2710 | Polymyxin E sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 27100 | Homoharringtonine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27100 | Homoharringtonine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27100 | Homoharringtonine | Designated preferred name (PT) | YES | |
| RxCUI: 27100 | Homoharringtonine | Full form of descriptor (FN) | YES | |
| RxCUI: 27104 | Homoisocitrate dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 27104 | Homoisocitrate dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 27109 | Homoserine acetyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 27109 | Homoserine acetyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 27110 | Homoserine kinase | Designated preferred name (PT) | NO | |
| RxCUI: 27110 | Homoserine kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 27111 | Homoserine o-transsuccinylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27111 | Homoserine o-transsuccinylase | Designated preferred name (PT) | NO | |
| RxCUI: 27111 | Homoserine o-transsuccinylase | Full form of descriptor (FN) | NO | |
| RxCUI: 27120 | hordenine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27130 | cefpirome | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27130 | cefpirome | Designated preferred name (PT) | NO | |
| RxCUI: 27130 | cefpirome | Full form of descriptor (FN) | NO | |
| RxCUI: 27130 | cefpirome | Designated preferred name (PT) | NO | |
| RxCUI: 27130 | cefpirome | Full form of descriptor (FN) | NO | |
| RxCUI: 2714 | Collagen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2714 | Collagen | Designated preferred name (PT) | YES | |
| RxCUI: 2714 | Collagen | Full form of descriptor (FN) | YES | |
| RxCUI: 2714 | Collagen | Designated preferred name (PT) | YES | |
| RxCUI: 2714 | Collagen | Full form of descriptor (FN) | YES | |
| RxCUI: 27152 | PPP - Human pancreatic polypeptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27152 | PPP - Human pancreatic polypeptide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27169 | leflunomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27169 | leflunomide | Designated preferred name (PT) | YES | |
| RxCUI: 27169 | leflunomide | Full form of descriptor (FN) | YES | |
| RxCUI: 27169 | leflunomide | Designated preferred name (PT) | YES | |
| RxCUI: 27169 | leflunomide | Full form of descriptor (FN) | YES | |
| RxCUI: 27171 | Hyaluronate lyase | Designated preferred name (PT) | NO | |
| RxCUI: 27171 | Hyaluronate lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 271743 | piperazine hexahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 271769 | Norcholestenol iodomethyl (131-I) | Designated preferred name (PT) | NO | |
| RxCUI: 271769 | Norcholestenol iodomethyl (131-I) | Full form of descriptor (FN) | NO | |
| RxCUI: 2718 | Collagen type III | Designated preferred name (PT) | NO | |
| RxCUI: 2718 | Collagen type III | Full form of descriptor (FN) | NO | |
| RxCUI: 27184 | Hydrargaphen | Designated preferred name (PT) | NO | |
| RxCUI: 27184 | Hydrargaphen | Full form of descriptor (FN) | NO | |
| RxCUI: 27184 | Hydrargaphen | Designated preferred name (PT) | NO | |
| RxCUI: 27184 | Hydrargaphen | Full form of descriptor (FN) | NO | |
| RxCUI: 27185 | Hydrastine | Designated preferred name (PT) | NO | |
| RxCUI: 27185 | Hydrastine | Full form of descriptor (FN) | NO | |
| RxCUI: 2719 | Collagen type IV | Designated preferred name (PT) | NO | |
| RxCUI: 2719 | Collagen type IV | Full form of descriptor (FN) | NO | |
| RxCUI: 27196 | Hydrocortisone butyrate propionate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27196 | Hydrocortisone butyrate propionate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27196 | Hydrocortisone butyrate propionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 27196 | Hydrocortisone butyrate propionate | Designated preferred name (PT) | YES | |
| RxCUI: 27196 | Hydrocortisone butyrate propionate | Full form of descriptor (FN) | YES | |
| RxCUI: 27197 | hydrocortisone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 27197 | hydrocortisone acetate | Designated preferred name (PT) | YES | |
| RxCUI: 27197 | hydrocortisone acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 27199 | hydrocortisone valerate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 27199 | hydrocortisone valerate | Designated preferred name (PT) | YES | |
| RxCUI: 27199 | hydrocortisone valerate | Full form of descriptor (FN) | YES |